Regeneron Pharmaceuticals, Inc. Stock Trading & 13F Insights

13F Portfolio Filings

  • Most recent 13F
    Q2 2025
  • Location
    tarrytown, NY
  • CIK
    0000872589
  • All SEC filings
Q2 2025
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

4

$1.49 B
ALNY, NTLA, ACET, ADVM
13F-HR
Aug 1, 2025
000110465925073115

6

$1.23 B
ALNY, NTLA, TSVT, ADVM
13F-HR
May 2, 2025
000110465925044118

6

$1.09 B
ALNY, NTLA, TSVT, ACET
13F-HR
Feb 7, 2025
000110465925010583